Heart Valve Disease News

Preclinical data for Neovasc Inc.'s Tiara? transcatheter mitral valve program ... - MarketWatch (press release)



Preclinical data for Neovasc Inc.'s Tiara? transcatheter mitral valve program ... 
MarketWatch (press release)
Neovasc Inc. (CVE:CA:NVC) , a developer of novel technologies to treat vascular disease, today announced that its TiaraTM technology under development for the transcatheter treatment of mitral valve disease will be featured in three scientific sessions ...

and more » 


Edwards SAPIEN XT Transcatheter Valve Continues to Achieve Positive Patient ... - MarketWatch (press release)



Edwards SAPIEN XT Transcatheter Valve Continues to Achieve Positive Patient ... 
MarketWatch (press release)
PARIS, May 17, 2012 (MARKETWIRE via COMTEX) -- Edwards Lifesciences Corporation (NYSE:EW) , the global leader in the science of heart valves and hemodynamic monitoring, today announced that data from its post-approval study involving 94 European ...

and more » 


Florida Hospital Pepin Heart Institute is the First in Hillsborough County to ... - EON: Enhanced Online News (press release)



Florida Hospital Pepin Heart Institute is the First in Hillsborough County to ... 
EON: Enhanced Online News (press release)
... Pepin Heart Institute has performed seven Transcatheter Aortic Valve Replacement (TAVR) procedures since March and is still the FIRST and ONLY hospital in Hillsborough County to offer this minimally-invasive, life-saving procedure for heart disease ...

and more » 


Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... - EON: Enhanced Online News (press release)



Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... 
EON: Enhanced Online News (press release)
Annuloplasty rings are indicated for repair of the mitral valve and are designed to remodel the anatomical shape of the mitral annulus, thus preventing further dilatation and minimizing the risk of late repair failures. Sorin's MEMO 3D Semi-Rigid ...

 


Lilavati introduces bio-prosthetic heart valve, 'Trifecta Valve' with 20-year ... - pharmabiz.com



Lilavati introduces bio-prosthetic heart valve, 'Trifecta Valve' with 20-year ... 
pharmabiz.com
This new technology is now available in India which can save your heart and can give you an increased life span of 20 years and more. Bhanumati Lakhani, a 69 years old patient who suffered from aortic heart valve disease, has got latest aortic valve ...

 


Causes of heart disease - Canada.com



Causes of heart disease 
Canada.com
Heart failure is caused by conditions that weaken the heart or affect its ability to pump blood. Coronary artery disease, heart attack, high blood pressure, diabetes, heart valve disease, heart enlargement, abnormal heart structures caused by inherited ...

 


Florida Hospital Pepin Heart Institute is the First in Hillsborough County to ... - MarketWatch (press release)



Florida Hospital Pepin Heart Institute is the First in Hillsborough County to ... 
MarketWatch (press release)
... performed seven Transcatheter Aortic Valve Replacement (TAVR) procedures since March and is still the FIRST and ONLY hospital in Hillsborough County to offer this minimally-invasive, life-saving procedure for heart disease patients who, until now, ...

and more » 


Key Clinical Data for St. Jude Medical's Structural Heart Technologies ... - EON: Enhanced Online News (press release)



Key Clinical Data for St. Jude Medical's Structural Heart Technologies ... 
EON: Enhanced Online News (press release)
Among the highlights are first-in-man and six-month data for the company's Portico ? Transcatheter Aortic Heart Valve and results from a multicenter study for AMPLATZER ? Cardiac Plug (ACP) technology. St. Jude Medical's Transcatheter Aortic Valve ...

and more » 


Mitralign Raises $35 Million Series D Financing - EON: Enhanced Online News (press release)



Mass High Tech
 
Mitralign Raises $35 Million Series D Financing 
EON: Enhanced Online News (press release)
(EON: Enhanced Online News)--Mitralign, Inc., a cardiac device company leading the way in percutaneous mitral valve repair, today announced the closing of a $35 million Series D round of funding. The round was led by Forbion Capital Partners, ...
Mitralign to use $35M round for mitral valve launch Mass High Tech
Mitralign Inks $35M Private Equity Hub (press release)

all 9 news articles » 


Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... - MarketWatch (press release)



Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty ... 
MarketWatch (press release)
Annuloplasty rings are indicated for repair of the mitral valve and are designed to remodel the anatomical shape of the mitral annulus, thus preventing further dilatation and minimizing the risk of late repair failures. Sorin's MEMO 3D Semi-Rigid ...

and more »